{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:21:18Z","timestamp":1769923278534,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12029-019-00250-9","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T09:32:35Z","timestamp":1558431155000},"page":"280-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An Examination of Lymph Node Sampling as a Predictor of Survival in Resected Node-Negative Small Bowel Adenocarcinoma: a SEER Database Analysis"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2460-5608","authenticated-orcid":false,"given":"Maclean","family":"Thiessen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M.","family":"Lee-Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G.","family":"Monzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"issue":"1","key":"250_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","volume":"249","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249(1):63\u201371. https:\/\/doi.org\/10.1097\/SLA.0b013e31818e4641.","journal-title":"Ann Surg"},{"issue":"6","key":"250_CR2","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1080\/0284186X.2018.1433321","volume":"57","author":"E de Bree","year":"2018","unstructured":"de Bree E, Rovers KP, Stamatiou D, Souglakos J, Michelakis D, de Hingh IH. The evolving management of small bowel adenocarcinoma. Acta Oncol. 2018;57(6):712\u201322. https:\/\/doi.org\/10.1080\/0284186X.2018.1433321.","journal-title":"Acta Oncol"},{"issue":"12","key":"250_CR3","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1111\/j.1572-0241.2006.00854.x","volume":"101","author":"C Lepage","year":"2006","unstructured":"Lepage C, Bouvier AM, Manfredi S, Dancourt V, Faivre J. Incidence and management of primary malignant small bowel cancers: a well-defined French population study. Am J Gastroenterol. 2006;101(12):2826\u201332. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00854.x.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"250_CR4","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1245\/s10434-010-1109-x","volume":"17","author":"MB Nicholl","year":"2010","unstructured":"Nicholl MB, Ahuja V, Conway WC, Vu VD, Sim MS, Singh G. Small bowel adenocarcinoma: understaged and undertreated? Ann Surg Oncol. 2010;17(10):2728\u201332. https:\/\/doi.org\/10.1245\/s10434-010-1109-x.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"250_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/cncr.20404","volume":"101","author":"BS Dabaja","year":"2004","unstructured":"Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101(3):518\u201326. https:\/\/doi.org\/10.1002\/cncr.20404.","journal-title":"Cancer"},{"issue":"6","key":"250_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/archsurg.135.6.635","volume":"135","author":"FG Bakaeen","year":"2000","unstructured":"Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg. 2000;135(6):635\u201341 discussion 641-632.","journal-title":"Arch Surg"},{"key":"250_CR7","unstructured":"British Columbia Cancer Agency (2018) Small Bowel Malignancies. http:\/\/www.bccancer.bc.ca\/health-professionals\/clinical-resources\/cancer-management-guidelines\/gastrointestinal\/small-bowel-malignancies. Accessed Sept 4 2018."},{"issue":"1","key":"250_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.dld.2017.09.123","volume":"50","author":"C Locher","year":"2018","unstructured":"Locher C, Batumona B, Afchain P, Carrere N, Samalin E, Cellier C, et al. Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis. 2018;50(1):15\u20139. https:\/\/doi.org\/10.1016\/j.dld.2017.09.123.","journal-title":"Dig Liver Dis"},{"key":"250_CR9","unstructured":"National Comprehensive Cancer Network Colon Cancer (Version 4.2018). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon_blocks.pdf. Accessed January 18, 2018."},{"issue":"4","key":"250_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cell.2009.02.037","volume":"137","author":"RA Phelps","year":"2009","unstructured":"Phelps RA, Chidester S, Dehghanizadeh S, Phelps J, Sandoval IT, Rai K, et al. A two-step model for colon adenoma initiation and progression caused by APC loss. Cell. 2009;137(4):623\u201334. https:\/\/doi.org\/10.1016\/j.cell.2009.02.037.","journal-title":"Cell"},{"key":"250_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/1477-3163.78111","volume":"10","author":"R Najdi","year":"2011","unstructured":"Najdi R, Holcombe RF, Waterman ML. Wnt signaling and colon carcinogenesis: beyond APC. J Carcinog. 2011;10:5. https:\/\/doi.org\/10.4103\/1477-3163.78111.","journal-title":"J Carcinog"},{"issue":"11","key":"250_CR12","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaoncol.2017.1051","volume":"3","author":"AB Schrock","year":"2017","unstructured":"Schrock AB, Devoe CE, McWilliams R, Sun J, Aparicio T, Stephens PJ, et al. Genomic profiling of small-bowel adenocarcinoma. JAMA Oncol. 2017;3(11):1546\u201353. https:\/\/doi.org\/10.1001\/jamaoncol.2017.1051.","journal-title":"JAMA Oncol"},{"issue":"4","key":"250_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3109\/02841860903490051","volume":"49","author":"MJ Overman","year":"2010","unstructured":"Overman MJ, Kopetz S, Lin E, Abbruzzese JL, Wolff RA. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol. 2010;49(4):474\u20139. https:\/\/doi.org\/10.3109\/02841860903490051.","journal-title":"Acta Oncol"},{"issue":"1","key":"250_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11938-000-0061-4","volume":"3","author":"A Tumbapura","year":"2000","unstructured":"Tumbapura A, Kuwada S, DiSario JA. Adenocarcinoma of the small intestine. Curr Treat Options Gastroenterol. 2000;3(1):51\u20137. https:\/\/doi.org\/10.1007\/s11938-000-0061-4.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"250_CR15","volume-title":"Surgical treatment: evidence-based and problem-oriented","author":"A Neugut","year":"2001","unstructured":"Neugut A, Marvin M, Chabot J. Adenocarcinoma of the small bowel. In: Holzheimer R, Mannick J, editors. Surgical treatment: evidence-based and problem-oriented. Munich: Zuckschwerdt; 2001."},{"issue":"1","key":"250_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clcc.2015.07.004","volume":"15","author":"CC Moreno","year":"2016","unstructured":"Moreno CC, Mittal PK, Sullivan PS, Rutherford R, Staley CA, Cardona K, et al. Colorectal cancer initial diagnosis: screening colonoscopy, diagnostic colonoscopy, or emergent surgery, and tumor stage and size at initial presentation. Clin Colorectal Cancer. 2016;15(1):67\u201373. https:\/\/doi.org\/10.1016\/j.clcc.2015.07.004.","journal-title":"Clin Colorectal Cancer"},{"issue":"4","key":"250_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1590\/S1679-45082015AO3380","volume":"13","author":"I Negoi","year":"2015","unstructured":"Negoi I, Paun S, Hostiuc S, Stoica B, Tanase I, Negoi RI, et al. Most small bowel cancers are revealed by a complication. Einstein (Sao Paulo). 2015;13(4):500\u20135. https:\/\/doi.org\/10.1590\/S1679-45082015AO3380.","journal-title":"Einstein (Sao Paulo)"},{"issue":"4","key":"250_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/DCR.0000000000000562","volume":"59","author":"JI Young","year":"2016","unstructured":"Young JI, Mongoue-Tchokote S, Wieghard N, Mori M, Vaccaro GM, Sheppard BC, et al. Treatment and survival of small-bowel adenocarcinoma in the United States: a comparison with colon cancer. Dis Colon Rectum. 2016;59(4):306\u201315. https:\/\/doi.org\/10.1097\/DCR.0000000000000562.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"250_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/cncr.29840","volume":"122","author":"BL Ecker","year":"2016","unstructured":"Ecker BL, McMillan MT, Datta J, Mamtani R, Giantonio BJ, Dempsey DT, et al. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: a propensity score-matched analysis. Cancer. 2016;122(5):693\u2013701. https:\/\/doi.org\/10.1002\/cncr.29840.","journal-title":"Cancer"},{"issue":"4","key":"250_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1200\/JOP.2016.017210","volume":"13","author":"J Kannarkatt","year":"2017","unstructured":"Kannarkatt J, Joseph J, Kurniali PC, Al-Janadi A, Hrinczenko B. Adjuvant chemotherapy for stage II colon cancer: a clinical dilemma. J Oncol Pract. 2017;13(4):233\u201341. https:\/\/doi.org\/10.1200\/JOP.2016.017210.","journal-title":"J Oncol Pract"},{"issue":"16","key":"250_CR21","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","volume":"22","author":"AB Benson 3rd","year":"2004","unstructured":"Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22(16):3408\u201319. https:\/\/doi.org\/10.1200\/JCO.2004.05.063.","journal-title":"J Clin Oncol"},{"issue":"Suppl 6","key":"250_CR22","doi-asserted-by":"publisher","first-page":"vi64","DOI":"10.1093\/annonc\/mdt354","volume":"24","author":"R Labianca","year":"2013","unstructured":"Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandala M, Cervantes A, et al. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi64\u201372. https:\/\/doi.org\/10.1093\/annonc\/mdt354.","journal-title":"Ann Oncol"},{"issue":"1","key":"250_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1245\/ASO.2003.03.058","volume":"10","author":"RS Swanson","year":"2003","unstructured":"Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10(1):65\u201371.","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"250_CR24","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1200\/JCO.2003.05.062","volume":"21","author":"TE Le Voyer","year":"2003","unstructured":"Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21(15):2912\u20139. https:\/\/doi.org\/10.1200\/JCO.2003.05.062.","journal-title":"J Clin Oncol"},{"key":"250_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ebiom.2018.05.022","volume":"32","author":"S Wu","year":"2018","unstructured":"Wu S, Chen JN, Zhang QW, Tang CT, Zhang XT, Tang MY, et al. A new metastatic lymph node classification-based survival predicting model in patients with small bowel adenocarcinoma: a derivation and validation study. EBioMedicine. 2018;32:134\u201341. https:\/\/doi.org\/10.1016\/j.ebiom.2018.05.022.","journal-title":"EBioMedicine"},{"issue":"2","key":"250_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.surg.2015.03.048","volume":"158","author":"TB Tran","year":"2015","unstructured":"Tran TB, Qadan M, Dua MM, Norton JA, Poultsides GA, Visser BC. Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma. Surgery. 2015;158(2):486\u201393. https:\/\/doi.org\/10.1016\/j.surg.2015.03.048.","journal-title":"Surgery"},{"key":"250_CR27","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973\u20132014), National Cancer Institute, DCCPS, Surveillance Research Program, released April 2017, based on the November 2016 submission."},{"key":"250_CR28","unstructured":"National Cancer Institute Overview of the SEER Program. National Institute of Health. https:\/\/seer.cancer.gov\/about\/overview.html. Accessed Dec 11 2018 2018."},{"issue":"10","key":"250_CR29","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. https:\/\/doi.org\/10.1371\/journal.pmed.1001885.","journal-title":"PLoS Med"},{"issue":"4","key":"250_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.currproblcancer.2012.03.011","volume":"36","author":"HS Park","year":"2012","unstructured":"Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Limitations and biases of the Surveillance, Epidemiology, and End Results database. Curr Probl Cancer. 2012;36(4):216\u201324. https:\/\/doi.org\/10.1016\/j.currproblcancer.2012.03.011.","journal-title":"Curr Probl Cancer"},{"key":"250_CR31","unstructured":"Gliklich RE, Dreyer NA, Leavy MB (2014) Registries for evaluating patient outcomes: a user\u2019s guide. Agency for Healthcare Research and Quality (US). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK208620\/. Accessed April 12 2019 2019."}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-019-00250-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-019-00250-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-019-00250-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T12:34:10Z","timestamp":1628598850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-019-00250-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["250"],"URL":"https:\/\/doi.org\/10.1007\/s12029-019-00250-9","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,20]]},"assertion":[{"value":"20 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As this research involved only de-identified patient data, it was exempt from ethical board review and informed consent was not required [].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}